YE L[au] - Search Results

Year	Number of Results
1981	1
1983	1
1984	1
1985	4
1986	4
1987	8
1989	6
1990	5
1991	6
1992	12
1993	13
1994	14
1995	12
1996	11
1997	13
1998	6
1999	23
2000	21
2001	25
2002	21
2003	37
2004	49
2005	71
2006	80
2007	100
2008	140
2009	163
2010	174
2011	210
2012	252
2013	301
2014	416
2015	407
2016	436
2017	537
2018	541
2019	629
2020	767
2021	846
2022	596
2023	1

1

Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.

Yang J, Mo J, Dai J, Ye C, Cen W, Zheng X, Jiang L, Ye L. Yang J, et al. Among authors: ye l. Cell Death Dis. 2021 Nov 13;12(11):1079. doi: 10.1038/s41419-021-04367-3. Cell Death Dis. 2021. PMID: 34775496 Free PMC article.

2

Advances in mRNA 5-methylcytosine modifications: Detection, effectors, biological functions, and clinical relevance.

Guo G, Pan K, Fang S, Ye L, Tong X, Wang Z, Xue X, Zhang H. Guo G, et al. Among authors: ye l. Mol Ther Nucleic Acids. 2021 Aug 26;26:575-593. doi: 10.1016/j.omtn.2021.08.020. eCollection 2021 Dec 3. Mol Ther Nucleic Acids. 2021. PMID: 34631286 Free PMC article. Review.

3

A cellular census of human peripheral immune cells identifies novel cell states in lung diseases.

Song D, Yan F, Fu H, Li L, Hao J, Zhu Z, Ye L, Zhang Y, Jin M, Dai L, Fang H, Song Z, Wu D, Wang X. Song D, et al. Among authors: ye l. Clin Transl Med. 2021 Nov;11(11):e579. doi: 10.1002/ctm2.579. Clin Transl Med. 2021. PMID: 34841705 Free PMC article.

4

A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy.

Ye L, Park JJ, Peng L, Yang Q, Chow RD, Dong MB, Lam SZ, Guo J, Tang E, Zhang Y, Wang G, Dai X, Du Y, Kim HR, Cao H, Errami Y, Clark P, Bersenev A, Montgomery RR, Chen S. Ye L, et al. Cell Metab. 2022 Apr 5;34(4):595-614.e14. doi: 10.1016/j.cmet.2022.02.009. Epub 2022 Mar 10. Cell Metab. 2022. PMID: 35276062

5

The kinase complex mTORC2 promotes the longevity of virus-specific memory CD4⁺ T cells by preventing ferroptosis.

Wang Y, Tian Q, Hao Y, Yao W, Lu J, Chen C, Chen X, Lin Y, Huang Q, Xu L, Hu J, Lei S, Wei Z, Luo Y, Li Z, Hu L, Tang J, Wu Q, Zhou X, Wu Y, Yin Z, Xu J, Ye L. Wang Y, et al. Among authors: ye l. Nat Immunol. 2022 Feb;23(2):303-317. doi: 10.1038/s41590-021-01090-1. Epub 2021 Dec 23. Nat Immunol. 2022. PMID: 34949833

6

Radical Reactions of Ynamides.

Tan TD, Wang ZS, Qian PC, Ye LW. Tan TD, et al. Among authors: ye lw. Small Methods. 2021 Mar;5(3):e2000673. doi: 10.1002/smtd.202000673. Epub 2020 Sep 29. Small Methods. 2021. PMID: 34927818 Review.

7

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.

Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Muñoz Navarro SR, Sued O, Lioznov DA, Dzutseva V, Parveen G, Zhu F, Leppan L, Langley JM, Barreto L, Gou J, Zhu T; CanSino COVID-19 Global Efficacy Study Group. Halperin SA, et al. Among authors: ye l. Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23. Lancet. 2022. PMID: 34953526 Free PMC article. Clinical Trial.

8

PP2A-mTOR-p70S6K/4E-BP1 axis regulates M1 polarization of pulmonary macrophages and promotes ambient particulate matter induced mouse lung injury.

Chen S, Chen L, Ye L, Jiang Y, Li Q, Zhang H, Zhang R, Li H, Yu D, Zhang R, Niu Y, Zhao Q, Liu J, Ouyang G, Aschner M, Zheng Y, Zhang L, Chen W, Li D. Chen S, et al. Among authors: ye l. J Hazard Mater. 2022 Feb 15;424(Pt C):127624. doi: 10.1016/j.jhazmat.2021.127624. Epub 2021 Oct 29. J Hazard Mater. 2022. PMID: 34740159

9

[Herbalogical study on Liangmianzhen (Zanthoxyli Radix)].

Wu MH, Ma ZG, Zhang Y, Ye LF, Cao H. Wu MH, et al. Among authors: ye lf. Zhongguo Zhong Yao Za Zhi. 2021 Oct;46(20):5436-5442. doi: 10.19540/j.cnki.cjcmm.202100803.101. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 34738447 Chinese.

10

Pediatric usage of Omalizumab: A promising one.

Yu L, Zhang H, Pan J, Ye L. Yu L, et al. Among authors: ye l. World Allergy Organ J. 2021 Dec 11;14(12):100614. doi: 10.1016/j.waojou.2021.100614. eCollection 2021 Dec. World Allergy Organ J. 2021. PMID: 34963793 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results